CdcA3 inhibitors represent a class of chemical compounds specifically designed to target and interfere with the function of the CdcA3 protein. CdcA3, also known as Cell Division Cycle A3, is a key regulatory protein that plays a pivotal role in controlling cell cycle progression and division. Inhibitors within this class are engineered to modulate the activity of CdcA3, primarily by disrupting its function and thereby influencing cellular processes governed by this protein. These inhibitors are designed with the aim of better understanding the intricate machinery of the cell cycle and its regulation.
The development of CdcA3 inhibitors has been driven by the scientific interest in unraveling the complexities of cell division and its molecular control. These inhibitors often work by binding to CdcA3 or its associated components, inhibiting its enzymatic activity, and consequently perturbing the precise timing and execution of cell division. By interfering with CdcA3's function, researchers can gain valuable insights into the fundamental processes that underlie cell cycle progression and division. This class of compounds serves as indispensable tools in cell biology and molecular biology research, facilitating the exploration of intricate mechanisms governing cell division, DNA replication, and related cellular events. The study of CdcA3 inhibitors has contributed significantly to our understanding of the molecular intricacies that govern the cell cycle, and continues to be a vital area of investigation in the realm of basic scientific research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ursodeoxycholic acid | 128-13-2 | sc-204935 sc-204935A | 1 g 5 g | $52.00 $131.00 | 4 | |
UDCA displaces CDCA3 from binding sites, reducing CDCA3-mediated inflammation and apoptosis in liver cells. | ||||||
Cholic acid | 81-25-4 | sc-255020 sc-255020A sc-255020B sc-255020C sc-255020D | 25 g 100 g 500 g 1 kg 5 kg | $49.00 $123.00 $578.00 $1018.00 $4570.00 | 11 | |
Cholic acid inhibits CDCA3 by acting as a natural FXR agonist, reducing hepatic inflammation and fibrosis. | ||||||
Tauroursodeoxycholic Acid, Sodium Salt | 14605-22-2 | sc-281165 | 1 g | $644.00 | 5 | |
TUDCA stabilizes the cell membrane and reduces CDCA3-mediated endoplasmic reticulum stress in hepatocytes. | ||||||
Lithocholic acid | 434-13-9 | sc-215262 sc-215262A | 10 g 25 g | $100.00 $272.00 | 1 | |
LCA inhibits CDCA3 by inducing FXR-mediated apoptosis of liver cells, reducing inflammation and fibrosis. | ||||||
Chenodeoxycholic acid, free acid | 474-25-9 | sc-278835 sc-278835A | 1 g 5 g | $28.00 $117.00 | ||
CDCA directly antagonizes CDCA3 signaling pathways, alleviating liver inflammation and bile acid accumulation. | ||||||
Dehydrocholic acid | 81-23-2 | sc-214863 sc-214863A | 25 g 50 g | $79.00 $146.00 | ||
DHCA inhibits CDCA3 through the activation of FXR, reducing hepatocellular damage and inflammation. | ||||||